ArticleCancer immunology, immunotherapy : CII2017

FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy.

Simona Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.